was present in the dialysate fluid in all patients and the concentration was 1.5 mEq/liter. None of the patients was ingesting Mg at the time of the study. The number of exchanges was four per day in most patients, and in those who had lower creatinine, three per day.
Most commonly, the renal disease was due to diabetes mellitus (20 patients), followed in frequency by chronic glomerulonephritis, polycystic disease, hypertension and others. None of the patients had undergone renal transplantation or parathyroidectomy. Table I provides information on the subjects and the follow-up examinations.
Our radiographic skeletal survey included postero-anterior fine-detail radiographs of both hands, both feet and lateral views of both ankles. The soft tissues in these three areas were scrutinized at x 6 magnification by a previously described method of microradioscopy [10, 111 which permits detection and a more reliable study of progression and regression of AC than a mere visual inspection of ordinary medical radiographs [12] . Examples of such progression and regression are shown in Figures 1 and 2 . A grading system was used for assessing the extent of and changes in AC, similar to a previously described grading of AC [13] .
Subperiosteal resorption in hand bones (a radiologic manifestation of hyperparathyroidism) was graded from 0 to 3 + by a previously described microradioscopic method [14] with a slight modification for follow-up purposes [15] .
Serum Ca and Mg were measured by atomic absorption spectrophotometry. Serum P and alkaline phosphatase were measured by the Technicon Autoanalyzer (Technicon Instruments, Tarrytown, New York, USA). Plasma iPTH was measured by a radioimmunoassay using an antiserum (GP-l) directed against both amino and carboxy terminal parts of the PTH molecule [16] .
The dose and duration of 1 ,25-D3 treatment and oral calcium supplementation were also recorded.
Results
The values of serum Ca, P, Mg, Ca >< P, P:Mg, Mg X Ca, Mg:Ca, (Ca x P):Mg, alkaline phosphatase and plasma iPTH were compared by analysis of variance between two groups of patients: 1) Group A, those who showed one or more increases of AC; and 2) Group B, patients in whom AC either did not Table 2 and for subgroups B1 and B2 in Table 3 . As shown in Table 2 , the analysis of variance revealed no significant differences for Ca, P, Ca x P. alkaline phosphatase and iPTH between groups A and B. Serum Mg levels, however, were significantly higher in Group B than in Group A (P < 0.001, Table 2 ), and the ratios and products including Mg also differed significantly between Groups A and B. Figure 3 depicts the individual values of serum Mg in Group A (AC progressed) and in the two subgroups B (AC did not develop) and B2 (AC regressed), in relation of our normal range of serum Mg (1.7 to 2.6 mg/dl). A comparison of the frequency of observations between Group A and Group B (B1+B2) revealed that when there was hypermagnesemia, progressions of AC occurred in 22 of 86 observations, while non-development or regressions were noted in 64 of 86 observations. Within the normomagnesemic range, however, the respective numbers were 22 of 34 and 12 of 34, the difference between these two sample proportions being significant by chi-square test (chi-square = 14.68, P < 0.001). When using various cut-off values for serum Mg, the value of our normal upper limit yielded the highest chi-square value, that is, the normal upper limit of serum Mg may be presumed to represent the degree of hypermagnesemia necessary to prevent or reduce AC. 
The two patients in whom AC first progressed and then regressed (Table 1) that when Ca x P product was above the normal range, progression of AC occurred in 30 observations, and nondevelopment or regressions in 53 observations. However, when Ca x P was within the normal range, the respective numbers were 14 and 23, the difference being statistically not significant (chi-square = 0.0045). Thus, a high serum Mg level is a much better biochemical index than a high Ca x P product for discriminating between those in whom AC regressed or did not develop during the follow-up (Group B) than those in whom they progressed (Group A).
It is also apparent from Table 2 that the differences in the means of Ca x P between groups A and B were entirely due to differences in P rather than Ca. One would therefore expect that the P:Mg ratio should be the best discriminator between those who developed AC and those who did not. However, the statistical significances between the groups were actually lower for P:Mg than for Mg alone. Surprisingly, they were also lower for P:Mg than for Mg:Ca and Mg x Ca (Tables 2 and 3 ).
As shown in Table 3 and Figure 3 , comparison of values between subgroups B1 (no development of AC) and B2 (regression of AC) showed that in Group B2 the mean serum Mg was higher and serum P lower than in Group B1. However, these differences were not statistically significant, probably because of the small number of observations in Group B2 (Table 3) .
Interestingly, both the alkaline phosphatase and iPTH were also higher in Group B2, although only the former attained borderline statistical significance.
Since AC occur and progress more commonly in patients with diabetes mellitus than in non-diabetics with end-stage renal disease [13] , we divided Group A into patients with diabetes (N of observations = 24) and those without (N of , and found no significant difference in their serum Mg levels (Fig. 4) . Interestingly, none of those who did not develop AC during the follow-up was diabetic. Comparison of Mg values of this group with non-diabetics who developed AC, also similar in age (Fig. 4) , showed that the mean value was significantly lower in the latter group (Student's t-test, P < 0.05). In the small group with decreasing AC, all except one observation showed distinctly elevated values of serum Mg; surprisingly, five of eight observations were in diabetics. A comparison of serum Mg values in those who had received l,25-D3 and those who had not showed no significant differences by Student's t-test. In patients receiving l,25-D3 supplementation, a comparison of serum Mg levels between those with progressive AC (mean value 2.78) and those in whom no AC developed (mean value 3.03) revealed no significant difference (t = 1.90, P < 0.1). It thus appears that 1 ,25-D3 and Mg are independent factors with respect to the development of arterial calcifications.
Only six patients had received calcium supplements, three with progressive AC and three without development of any.
Although the biochemical parameters of parathyroid function-iPTH and alkaline phosphatase-did not show any significant difference between Group A and B (Table 2) , a comparison of the grades of radiological subperiosteal resorption between Groups A and B1 showed that the mean grade of 1.30 in the former group was significantly higher than that of 0.92 in the latter by Student's t-test (P < 0.05). This suggests that hyperparathyroidism, at the skeletal level, is slightly more prevalent in patients with progressive AC than in those without AC.
Interestingly, in Group B2, in which AC regressed, the average grade of 1.38 of subperiosteal resorption was actually the highest. This, however, can be explained by the finding of a previous study that subperiosteal resurption is significantly more marked in younger than in older patients with end-stage renal disease [15] . The average age in this small subgroup of five patients was more than 10 years lower than in other subgroups (Table I) . Hyperparathyroidism is known to be less prevalent in diabetics than in non-diabetics, both by biochemical and radiological criteria [17, 18] . We therefore compared grading of subperiosteal resorption in the non-diabetic Group with that of the non-diabetics in Group A and found a significant difference between these two groups (means of 0.92 and 1.63, respectively, P < 0.01). This indicates an increased incidence of hyperparathyroidism in patients with progressive AC compared to those without.
Discussion
Although it has been previously suggested that a high serum Ca x P product is one of the principal factors in the development of AC in end-stage renal disease [1] [2] [3] [4] [5] , there have been some recent studies [6] [7] [8] that have failed to show any clear-cut relationship. Thus, in the study by DeFrancisco et al [8] , the presence or absence of soft tissue calcifications in 62 patients with secondary hyperparathyroidism of chronic renal failure was found to be unrelated to serum Ca, P, Ca x P, Mg, alkaline phosphatase, plasma iPTH levels, radiologic erosions, severity of histologic osteitis fibrosa or parathyroid gland weight.
Our findings have also shown poor relationship between the AC and Ca, P, Ca X P, alkaline phosphatase and iPTH, but a highly significant relationship with serum Mg levels. The reasons why such relationships have not been detected previously appear largely methodological. In the present study, which is a longitudinal rather than cross-sectional one, we have made use of fine-detail radiographs enabling magnification and therefore a more confident recognition of slight changes in AC.
In accordance with previous findings of frequent hypermagnesemia in patients with end-stage renal disease [7, 8, [19] [20] [21] , hypermagnesemia was also common in our patients. The mean serum Mg, however, was lower in those in whom AC progressed than in others in whom AC did not develop (Fig. 3) ; in the small group of observations where AC regressed, the mean serum Mg was even higher. On the other hand, the higher than normal mean serum Ca x P values did not differ significantly among the three groups (Fig. 3) .
Although it has been suggested that serum Mg levels poorly reflect the intracellular Mg content and that in patients with renal failure hypermagnesemia may be accompanied by tissue Mg depletion [22] [23] [24] or normal tissue Mg content [25] , it is nevertheless possible that the lower than average serum Mg levels seen when AC progresses may facilitate the calcification in the media of the arteries since Mg is a potent inhibitor of the calcification process [26] [27] [28] .
Another possibility is that the higher serum Mg prevented AC by suppressing the secretion of PTH [29] [30] [31] [32] . This view is not supported by our data in that iPTH levels did not differ significantly between any of the subgroups and subperiosteal resorption was actually greater in those in whom AC were progressive.
As has been previously suggested [9] , l-alpha-hydroxycholecalciferol treatment may promote the development of AC in uremic rats. Our findings indicate that this mechanism may also be operative in humans suffering from end-stage renal disease in that treatments with l,25-D3 had been more frequent in patients with progressive AC than in those without development of AC. This effect of I ,25-D3, however, appeared to be independent of that of serum magnesium.
It has been shown that Mg is a potent inhibitor of the calcification process [26] [27] [28] and that experimental Mg deficiency appears to promote AC [33] [34] . It has also been suggested that a high Mg intake (such as, hard versus soft drinking water) may have an inhibitory effect on atherogenesis [35] [36] [37] and on acute cardiac ischemic attacks [38] [39] [40] [41] . Furthermore, peroral magnesium hydroxide therapy has significantly improved the performance in patients with intermittent claudication [42] . These observations support the view that hypermagnesemia in end-stage renal disease may also be a causal factor in retarding the development of arterial calcifications. It is often stated that arterial medial calcifications (Monckeberg's sclerosis) are of little clinical consequence, being often found in asymptomatic patients [2, [43] [44] [45] [46] [47] [48] [49] [50] . These authors have ignored evidence (including the original observations by Monckeberg [51] ) clearly demonstrating that at least in chronic renal failure and in diabetes mellitus, AC in the media of medium-sized and small vessels are often very marked, and may displace intima causing luminal narrowing and leading to ischemia and gangrene [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] . One of the most convincing of these studies included histologic examinations of 20 amputated limbs by Ferrier [54] . He found that, out of a total of 16 arteries with advanced medial calcification, 15 were obstructed. The calcifications were more frequent in diabetic than in nondiabetic patients. In one of our recent studies on diabetics with end-stage renal disease, the incidence of amputations was five of 71(7%) and very marked AC were found in all five patients [13] . Others have reported an even higher incidence of amputations (up to 21%) in diabetics with end-stage renal disease [63] .
On the basis of these and similar observations, and in order to restore the real meaning of "Monckeberg's sclerosis", we have recently suggested a concept of two clinically and histologically different types of medial calcifications [12] : 1) a benign slowly progressive, essentially asymptomatic form with thin medial calcifications and little or no narrowing of the arterial lumen; and 2) a malignant, rapidly progressive type in which massive and extensive medial calcifications may displace the internal elastica toward the lumen (and even break through into the intima) causing luminal narrowing. Although the observations leading to these conclusions have been made in the peripheral arteries, they may also be applicable to the coronary arteries since, contrary to some reports [45, 48, 64] , medial calcifications are indeed found in the arteries of the heart [65] [66] [67] [68] [69] [70] , thus possibly further contributing to the known high prevalence of cardiovascular complications in chronically dialyzed patients [71] [72] [73] .
It therefore appears that further studies on AC are indeed necessary, including those concerned with possible protective role of modest hypermagnesemia. The serum Mg levels rarely exceeded 4 mg/dl in our patients, well below the levels of reported acute Mg toxicity [74] [75] [76] . The possibility, however, that such hypermagnesemia in patients with chronic renal failure [29] [30] [31] [32] also increases the concentration of Mg in bone and that this may interfere with the normal mineralization process [77, 78] , should also be further explored.
